Devon Rachael Layton, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2126 Highway 9 E Ste C4, Longs, SC 29568 Phone: 843-734-1076 Fax: 843-734-1107 |
Michael Therapy Services Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 213 Forest Dr, Longs, SC 29568 Phone: 740-988-6713 Fax: 854-600-1552 |
Katelyn Dinkowitz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2126 Highway 9 E Ste C4, Longs, SC 29568 Phone: 843-734-1076 |
Miss Cailin Brooke Michael, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2126 Highway 9 E Ste C4, Longs, SC 29568 Phone: 843-734-1076 Fax: 843-734-1107 |
Katie Lyn Morrison, M.A., CCC- SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2126 Highway 9 E Ste C4, Longs, SC 29568 Phone: 843-734-1076 |
Laura Britney Thompson, MA, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2126 Highway 9 E Ste C4, Longs, SC 29568 Phone: 842-734-1076 Fax: 843-734-1107 |
News Archive
Treatment of early-stage prostate cancer may also improve quality of life if patients have previously suffered from obstructive urinary symptoms before undergoing treatment, shows US research.
Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, according to a new study co-led by researchers at Johns Hopkins Bloomberg School of Public Health.
Our sense of belonging to the male or female gender is an inherent component of the human identity perception. As a general rule, gender identity and physical sex coincide. If this is not the case, one refers to trans-identity or transsexuality. In a current study, brain researcher Georg S. Kanz of the University Clinic for Psychiatry and Psychotherapy of the MedUni Vienna was able to demonstrate that the very personal gender identity of every human being is reflected and verifiable in the cross-links between brain regions.
Silence Therapeutics plc, a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today provides a year-end update on trading and the offer-period.
› Verified 9 days ago